搜索筛选:
搜索耗时3.4205秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
[期刊论文] 作者：Rilan Bai,Wenqian Li,Nawen Du,,
来源：中国癌症研究:英文版 年份：2019
Immunotherapy is one of the most promising treatments for multiple tumor types.The significant clinical benefits and durable responses of immunotherapy have led...
[期刊论文] 作者：Rilan Bai,Ling Bai,Wei Li,Jiu,
来源：肿瘤营养学杂志(英文) 年份：2017
Recent studies have shown that reprogramming of cholesterol metabolism occurs in both tumor cells and immune cells.Therapeutic strategies to inhibit the cholest...
[期刊论文] 作者：Rilan Bai,Wenqian Li,Nawen Du,Jiuwei Cui,
来源：中国癌症研究（英文版） 年份：2019
Immunotherapy is one of the most promising treatments for multiple tumor types.The significant clinical benefits and durable responses of immunotherapy have led...
[期刊论文] 作者：Rilan Bai,Lingyu Li,Xiao Chen,Yuguang Zhao,Wei Song,Huimin Tian,Jiuwei Cui,
来源：中国癌症研究:英文版 年份：2021
Small cell lung cancer(SCLC)is a high-grade neuroendocrine(NE)cancer characterized by high circulating tumor-cell burden and early extensive metastasis.Considering the complexity of SCLC genes and the immune microenvironment,their unique mo......
[会议论文] 作者：Wenqian Li,Rilan Bai,Lei Qian,Naifei Chen,Yuguang Zhao,Fujun Han,Ling Bai,Jiaxuan Li,Yu Yu,Jiuwei Cui,
来源：2019中国肿瘤学大会 年份：2019
Objective Lung cancer has been the leading cause of cancer death,among which approximately 80%is non-small cell lung cancer(NSCLC),besides,NSCLC patients with brain metastases had a poor prognosis.Mor...
Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse ev
[期刊论文] 作者：Rilan Bai,Naifei Chen,Xiao Chen,Lingyu Li,Wei Song,Wei Li,Yuguang Zhao,Yongfei Zhang,Fujun Han,Zheng,
来源：癌症生物学与医学（英文版） 年份：2021
Objective: We aimed to retrospectively analyze the toxicity profiles and predictors of immune-related adverse events (irAEs) as well as the correlation between irAEs and the clinical efficacy of multi-type immune checkpoint inhibitors (ICIs......
相关搜索：
